Skip to main content
. 2021 Jun 23;9(1):10.1128/spectrum.00102-21. doi: 10.1128/spectrum.00102-21

TABLE 2.

Strains, plasmids, and primers used in this study

Strain or plasmid Relevant characteristics or sequence (5′→3′)a Source or Reference
Strains
    E. coli
        TOP10 General cloning and blue/white screening Life Technologies
        E. cloni 10G General cloning and blue/white screening Lucigen
        S17-1 Mobilizing strain with transfer genes of RP4 integrated on chromosome, Smr, Tpr 66
        INV110 dam and dcm deficiencies to allow restriction digestion with Dam- and Dcm-sensitive restriction enzymes Invitrogen
    B. pseudomallei
        1026b Isolated in Thailand from a human case of septicemic melioidosis with skin, soft tissue, and spleen involvement, Pmr 59
        Bp82 1026b ΔpurM derivative; adenine and thiamine auxotroph 60
        SMM1 Bp82 derivative, hmqA::TnMod-OKm′ This study
        SMM2 Bp82 derivative, hmqD::TnMod-OKm′ This study
        Bp82 ΔhmqA Bp82 derivative harboring a 438-bp in-frame deletion mutation in hmqAhmqA) This study
        Bp82 ΔhmqD Bp82 derivative harboring a 318-bp in-frame deletion mutation in hmqDhmqD) This study
        Bp82 ΔhmqF Bp82 derivative harboring a 948-bp in-frame deletion mutation in hmqFhmqF) This study
        K96243 Isolated in Thailand from a diabetic patient with a clinical history of short incubation, septicemic infection, and rapid progression to death 58
        MSHR346 Isolated in 1995 from the sputum of a melioidosis patient admitted to Royal Darwin Hospital, Northern Territory, Australia P. Keim
Plasmids
    pCR2.1-TOPO 3,931-bp TA vector, pMB1 oriR, Kmr, Apr Life Technologies
    pCR2.1-hmqA pCR2.1-TOPO containing 1,639-bp PCR product generated with hmqA-up and hmqA-dn This study
    pCR2.1-ΔhmqA pCR2.1-hmqA digested with MluI and religated resulting in a 438-bp in-frame deletion in hmqA This study
    pCR2.1-hmqD pCR2.1-TOPO containing 1,142-bp PCR product generated with hmqD-up and hmqD-dn This study
    pCR2.1-ΔhmqD pCR2.1-hmqD digested with ClaI and religated resulting in a 318-bp in-frame deletion in hmqD This study
    pCR2.1-hmqF pCR2.1-TOPO containing 1,995-bp PCR product generated with hmqF-up and hmqF-dn This study
    pTnMod-OKm′ Minitransposon vector, pMB1 oriR, RP4 oriT, Tn5 tnp, Kmr 39
    pSMM1No Plasmid obtained from SMM1 by in vitro cloning with NotI This study
    pSMM2No Plasmid obtained from SMM2 by in vitro cloning with NotI This study
    pMo130 Suicide vector for allelic exchange in Burkholderia, ColE1 ori, RK2 oriT xylE sacB, Kmr 62
    pMo130-ΔhmqA pMo130 containing the NheI insert from pCR2.1-ΔhmqA This study
    pMo130-ΔhmqD pMo130 containing the SpeI-XbaI insert from pCR2.1-ΔhmqD cloned into the NheI site This study
    pMo130-hmqF pMo130 containing the SpeI-XbaI insert from pCR2.1-hmqF cloned into the NheI site This study
    pMo130-ΔhmqF pMo130-hmqF digested with BclI and religated resulting in a 948-bp in-frame deletion in hmqF This study
    pBHR2 Broad-host-range plasmid, Kmr 19
    pBHR2-hmqA pBHR2 containing EcoRI insert from pCR2.1-hmqA, constitutively expresses hmqA This study
    pBHR2-hmqD pBHR2 containing EcoRI insert from pCR2.1-hmqD, constitutively expresses hmqD This study
    pBHR2-hmqF pBHR2 containing EcoRI insert from pCR2.1-hmqF, constitutively expresses hmqF This study
Primers
    553F GTGCCAGCAGCCGCGGTAA 35
    1492R ACCTTGTTACGACTT 36
    Rd1 AAGGAGGTGATCCAGCC 67
    Fd1 AGTTTGATCCTGGCTCAG 67
    M13 Forward GTAAAACGACGGCCAG Life Technologies
    M13 Reverse CAGGAAACAGCTATGAC Life Technologies
    TnMod-LT2 TTCCTGGTACCGTCGACATG This study
    hmqA-up GCTAGCGTGAGCACTGACGATGGAC This study
    hmqA-dn GCTAGCTCAGGCCGCCTGCACGTCTTC This study
    hmqD-up TCGCCGCGGCGTCGTGAAGC This study
    hmqD-dn TCAGCTTCGATAGAGCGCGC This study
    hmqF-up ACGAACAACTCGCGACGCTC This study
    hmqF-dn ACTCCGAGCCGAGGATCTTC This study
a

r, resistant; s, susceptible; Sm, streptomycin; Tp, trimethoprim; Pm, polymyxin B; Km, kanamycin; Ap, ampicillin.